milrinone has been researched along with Right Ventricular Dysfunction in 25 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to investigate the postoperative hemodynamic effects of milrinone inhalation, and determine whether it has a selective effect of pulmonary vasodilation in patients with pulmonary hypertension undergoing mitral valve replacement surgery." | 9.14 | Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. ( Dai, A; Gong, M; Wang, H; Zhou, B, 2009) |
| "Milrinone has been proposed as an effective treatment for pulmonary hypertension (PH) and right ventricular (RV) dysfunction." | 7.81 | Treatment of premature infants with pulmonary hypertension and right ventricular dysfunction with milrinone: a case series. ( Bee, C; Corcoran, JD; El-Khuffash, AF; Franklin, O; James, AT; McNamara, PJ, 2015) |
| "In the setting of monocrotaline pyrrole-induced recipient pulmonary hypertension, milrinone was associated with significant improvements in pulmonary vascular impedance, right ventricular function, and transpulmonary efficiency." | 7.70 | Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. ( Bittner, HB; Chen, EP; Davis, RD; Van Trigt, P, 1998) |
| "Milrinone use was associated with an improvement in systolic and diastolic function in the RV, corresponding to an improvement in clinical status." | 5.38 | Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients. ( Patel, N, 2012) |
| " The aim of this study was to investigate the postoperative hemodynamic effects of milrinone inhalation, and determine whether it has a selective effect of pulmonary vasodilation in patients with pulmonary hypertension undergoing mitral valve replacement surgery." | 5.14 | Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. ( Dai, A; Gong, M; Wang, H; Zhou, B, 2009) |
| "Milrinone has been proposed as an effective treatment for pulmonary hypertension (PH) and right ventricular (RV) dysfunction." | 3.81 | Treatment of premature infants with pulmonary hypertension and right ventricular dysfunction with milrinone: a case series. ( Bee, C; Corcoran, JD; El-Khuffash, AF; Franklin, O; James, AT; McNamara, PJ, 2015) |
| "In the setting of monocrotaline pyrrole-induced recipient pulmonary hypertension, milrinone was associated with significant improvements in pulmonary vascular impedance, right ventricular function, and transpulmonary efficiency." | 3.70 | Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. ( Bittner, HB; Chen, EP; Davis, RD; Van Trigt, P, 1998) |
| "This study was designed to examine the effects of both nitric oxide and milrinone on pulmonary hemodynamics and right ventricular function using a newly established model of monocrotaline pyrrole-induced chronic pulmonary hypertension." | 3.69 | Right ventricular failure--insights provided by a new model of chronic pulmonary hypertension. ( Bittner, HB; Chen, EP; Davis, RD; Van Trigt, P, 1997) |
| "Iloprost was administered during weaning from cardiopulmonary bypass (CPB)." | 2.73 | Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. ( Autschbach, R; Buhre, W; de Waal, EE; Flier, S; Metzelder, S; Rex, S; Rossaint, R; Schaelte, G, 2008) |
| "Dobutamine-treated animals had lower perfusion pressures and blood pH compared with epinephrine + milrinone and dopamine + milrinone groups." | 1.40 | Inotropic therapy for right ventricular failure in newborn piglets: effect on contractility, hemodynamics, and interventricular interaction. ( Frederiksen, CA; Heiberg, J; Hyldebrandt, JA; Ravn, HB; Redington, AN; Rothmann, S; Schmidt, MR, 2014) |
| "Milrinone use was associated with an improvement in systolic and diastolic function in the RV, corresponding to an improvement in clinical status." | 1.38 | Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients. ( Patel, N, 2012) |
| "Severe pulmonary thromboembolism has been occasionally reported during orthotopic liver transplantation, with fatal outcomes occurring in about 50% of cases because of low cardiac output and multiple organ failure." | 1.33 | Cardiovascular collapse due to massive pulmonary thromboembolism during orthotopic liver transplantation. ( Ellenberger, C; Giostra, E; Licker, M; Mentha, G, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 11 (44.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elmi-Sarabi, M | 4 |
| Couture, E | 2 |
| Jarry, S | 3 |
| Saade, E | 2 |
| Calderone, A | 3 |
| Potes, C | 2 |
| Denault, A | 3 |
| Sia, YT | 1 |
| Gebhard, CE | 3 |
| Denault, AY | 4 |
| Coleman, RD | 1 |
| Chartan, CA | 1 |
| Mourani, PM | 1 |
| Uriel, N | 1 |
| Burkhoff, D | 1 |
| Kim, G | 1 |
| Silverstein, T | 1 |
| Juricek, C | 1 |
| Kaye, DM | 1 |
| Sayer, G | 1 |
| Hammoud, A | 1 |
| Couture, EJ | 3 |
| Sabato, LA | 1 |
| Salerno, DM | 1 |
| Moretz, JD | 1 |
| Jennings, DL | 1 |
| Tremblay, JA | 1 |
| Lamarche, Y | 1 |
| Heringlake, M | 1 |
| Berggreen, AE | 1 |
| Rochon, A | 1 |
| Cogan, J | 1 |
| Ased, H | 1 |
| Desjardins, G | 2 |
| Deschamps, A | 1 |
| Gavra, P | 2 |
| Lebon, JS | 1 |
| Couture, P | 1 |
| Ayoub, C | 1 |
| Levesque, S | 1 |
| Hyldebrandt, JA | 2 |
| Frederiksen, CA | 2 |
| Heiberg, J | 2 |
| Rothmann, S | 1 |
| Redington, AN | 1 |
| Schmidt, MR | 1 |
| Ravn, HB | 2 |
| James, AT | 1 |
| Bee, C | 1 |
| Corcoran, JD | 1 |
| McNamara, PJ | 1 |
| Franklin, O | 1 |
| El-Khuffash, AF | 1 |
| Haglund, NA | 1 |
| Burdorf, A | 1 |
| Jones, T | 1 |
| Shostrom, V | 1 |
| Um, J | 1 |
| Ryan, T | 1 |
| Shillcutt, S | 1 |
| Fischer, P | 1 |
| Cox, ZL | 1 |
| Raichlin, E | 1 |
| Anderson, DR | 1 |
| Lowes, BD | 1 |
| Dumitru, I | 1 |
| Sivén, E | 1 |
| Agger, P | 1 |
| Wemmelund, KB | 1 |
| Gebhard, C | 1 |
| Patel, ND | 1 |
| Weiss, ES | 1 |
| Schaffer, J | 1 |
| Ullrich, SL | 1 |
| Rivard, DC | 1 |
| Shah, AS | 1 |
| Russell, SD | 1 |
| Conte, JV | 1 |
| Wang, H | 1 |
| Gong, M | 1 |
| Zhou, B | 1 |
| Dai, A | 1 |
| Patel, N | 1 |
| Giaccone, A | 1 |
| Kirpalani, H | 1 |
| Ellenberger, C | 1 |
| Mentha, G | 1 |
| Giostra, E | 1 |
| Licker, M | 1 |
| Rex, S | 1 |
| Schaelte, G | 1 |
| Metzelder, S | 1 |
| Flier, S | 1 |
| de Waal, EE | 1 |
| Autschbach, R | 1 |
| Rossaint, R | 1 |
| Buhre, W | 1 |
| Chen, EP | 2 |
| Bittner, HB | 2 |
| Davis, RD | 2 |
| Van Trigt, P | 2 |
| Stobierska-Dzierzek, B | 1 |
| Awad, H | 1 |
| Michler, RE | 1 |
| Ricksten, S | 1 |
| Kihara, S | 1 |
| Kawai, A | 1 |
| Fukuda, T | 1 |
| Yamamoto, N | 1 |
| Aomi, S | 1 |
| Nishida, H | 1 |
| Endo, M | 1 |
| Koyanagi, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Validation of Cerebral Non-invasive Monitoring and Prediction of Post-operative Delirium and Outcomes: A Prospective Observational Study[NCT04643834] | 151 participants (Anticipated) | Observational | 2019-11-21 | Recruiting | |||
| Comparative Study Between Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension Undergoing Cardiac Surgery[NCT04484675] | Phase 4 | 38 participants (Anticipated) | Interventional | 2022-01-20 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for milrinone and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Intensive care management of right ventricular failure and pulmonary hypertension crises.
Topics: Biomarkers; Capnography; Central Venous Pressure; Critical Care; Echocardiography; Epinephrine; Epop | 2021 |
Inhaled Pulmonary Vasodilator Therapy for Management of Right Ventricular Dysfunction after Left Ventricular Assist Device Placement and Cardiac Transplantation.
Topics: Administration, Inhalation; Heart Transplantation; Heart-Assist Devices; Humans; Iloprost; Milrinone | 2017 |
The evolving management of acute right-sided heart failure in cardiac transplant recipients.
Topics: Alprostadil; Animals; Cardiotonic Agents; Epoprostenol; Heart Transplantation; Heart-Assist Devices; | 2001 |
[The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in heart].
Topics: Acute Disease; Administration, Inhalation; Cardiac Surgical Procedures; Cyclic AMP; Drug Synergism; | 2001 |
3 trials available for milrinone and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Inhaled Milrinone After Left Ventricular Assist Device Implantation.
Topics: Administration, Inhalation; Aged; Cost-Benefit Analysis; Female; Heart Failure; Heart Ventricles; He | 2015 |
Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery.
Topics: Administration, Inhalation; Adult; Analysis of Variance; Cardiac Output; Cardiopulmonary Bypass; Fem | 2009 |
Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
Topics: Administration, Inhalation; Aged; Cardiac Output, Low; Cardiopulmonary Bypass; Catheterization, Swan | 2008 |
18 other studies available for milrinone and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Inhaled Epoprostenol and Milrinone Effect on Right Ventricular Pressure Waveform Monitoring.
Topics: Adult; Cohort Studies; Epoprostenol; Humans; Hypertension, Pulmonary; Milrinone; Prospective Studies | 2023 |
Inhaled Epoprostenol and Milrinone Effect on Right Ventricular Pressure Waveform Monitoring.
Topics: Adult; Cohort Studies; Epoprostenol; Humans; Hypertension, Pulmonary; Milrinone; Prospective Studies | 2023 |
Inhaled Epoprostenol and Milrinone Effect on Right Ventricular Pressure Waveform Monitoring.
Topics: Adult; Cohort Studies; Epoprostenol; Humans; Hypertension, Pulmonary; Milrinone; Prospective Studies | 2023 |
Inhaled Epoprostenol and Milrinone Effect on Right Ventricular Pressure Waveform Monitoring.
Topics: Adult; Cohort Studies; Epoprostenol; Humans; Hypertension, Pulmonary; Milrinone; Prospective Studies | 2023 |
Reversal of Acute Right Ventricular Failure Early Post Left Ventricular Assist Device Placement by Intratracheal Milrinone Administration: Case Report.
Topics: Cardiotonic Agents; Echocardiography, Transesophageal; Heart Failure; Heart-Assist Devices; Humans; | 2021 |
Oral Milrinone for the Treatment of Chronic Severe Right Ventricular Failure in Left Ventricular Assist Device Patients.
Topics: Administration, Oral; Cardiotonic Agents; Combined Modality Therapy; Female; Heart-Assist Devices; H | 2021 |
Femoral Vein Pulsatility: What Does It Mean?
Topics: Aged; Cardiac Surgical Procedures; Femoral Vein; Humans; Milrinone; Portal Vein; Pulsatile Flow; Ven | 2021 |
Noninvasive Administration of Inhaled Epoprostenol and Inhaled Milrinone in Extubated, Spontaneously Breathing Patients With Right Ventricular Failure and Portal Hypertension: A Report of 2 Cases.
Topics: Administration, Inhalation; Aged; Airway Extubation; Antihypertensive Agents; Cardiac Surgical Proce | 2019 |
Intratracheal Milrinone for Acute Right Heart Dysfunction: Another Tool in the Pocket.
Topics: Cardiopulmonary Bypass; Heart Failure; Humans; Milrinone; Retrospective Studies; Ventricular Dysfunc | 2019 |
Acute Right Ventricular Failure in Cardiac Surgery During Cardiopulmonary Bypass Separation: A Retrospective Case Series of 12 Years' Experience With Intratracheal Milrinone Administration.
Topics: Acute Disease; Aged; Cardiopulmonary Bypass; Cardiotonic Agents; Echocardiography, Transesophageal; | 2019 |
Inotropic therapy for right ventricular failure in newborn piglets: effect on contractility, hemodynamics, and interventricular interaction.
Topics: Animals; Animals, Newborn; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Dobutamine; D | 2014 |
Treatment of premature infants with pulmonary hypertension and right ventricular dysfunction with milrinone: a case series.
Topics: Blood Pressure; Echocardiography; Female; Fetofetal Transfusion; Humans; Hypertension, Pulmonary; In | 2015 |
Effects of milrinone and epinephrine or dopamine on biventricular function and hemodynamics in an animal model with right ventricular failure after pulmonary artery banding.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dopamine; Epinephrine; Heart Failure; Heart Ven | 2015 |
Intratracheal Milrinone Bolus Administration During Acute Right Ventricular Dysfunction After Cardiopulmonary Bypass.
Topics: Aged; Cardiopulmonary Bypass; Cardiotonic Agents; Cohort Studies; Female; Humans; Intubation, Intrat | 2017 |
Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
Topics: Blood Pressure; Epinephrine; Female; Heart-Assist Devices; Hemodynamics; Humans; Length of Stay; Mal | 2008 |
Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients.
Topics: Antihypertensive Agents; Arterial Pressure; Cardiotonic Agents; Diastole; Echocardiography, Doppler; | 2012 |
Judgment often impossible without randomized trials. Commentary on N. Patel: use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients (Neonatology 2012;102:
Topics: Antihypertensive Agents; Cardiotonic Agents; Familial Primary Pulmonary Hypertension; Female; Hernia | 2012 |
Cardiovascular collapse due to massive pulmonary thromboembolism during orthotopic liver transplantation.
Topics: Aprotinin; Blood Pressure; Bronchodilator Agents; Cardiotonic Agents; Catheterization, Swan-Ganz; Ec | 2006 |
Right ventricular failure--insights provided by a new model of chronic pulmonary hypertension.
Topics: Administration, Inhalation; Animals; Blood Pressure; Cardiac Output; Dogs; Heart Rate; Hemodynamics; | 1997 |
Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension.
Topics: Animals; Dogs; Heart Transplantation; Hemodynamics; Hypertension, Pulmonary; Milrinone; Monocrotalin | 1998 |
Effects of milrinone for right ventricular failure after left ventricular assist device implantation.
Topics: Adolescent; Cardiotonic Agents; Heart Failure; Humans; Male; Middle Aged; Milrinone; Pacemaker, Arti | 2002 |